Welcome to our dedicated page for Enova Intl SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how Enova International funds high-velocity online loans or how rising delinquency rates impact margins often requires piecing together hundreds of pages across multiple forms. From securitization footnotes to state-specific lending caps, the disclosures can be daunting. If you’ve ever searched for “Enova International insider trading Form 4 transactions” or “Enova International quarterly earnings report 10-Q filing,” you know the challenge: the data exists, but it’s scattered.
Stock Titan solves that problem. Our AI-powered engine delivers “Enova International SEC filings explained simply,” turning raw documents into clear insights. Need “Enova International Form 4 insider transactions real-time” alerts? We surface them the moment they hit EDGAR and highlight which executive bought or sold. Want an “Enova International annual report 10-K simplified” walkthrough that pinpoints credit loss trends, funding costs, and regulatory risks? One click. Our coverage spans every filing type—10-Q, 8-K, DEF 14A, S-3—plus redlined comparisons and keyword search, so “understanding Enova International SEC documents with AI” becomes part of your daily workflow.
The platform connects filing types to what matters for a consumer-lending fintech. The 10-Q reveals net charge-offs; we transform that into a quarter-over-quarter chart for “Enova International earnings report filing analysis.” The proxy shows “Enova International proxy statement executive compensation,” including pay metrics tied to loan performance. Form 4 feeds flag “Enova International executive stock transactions Form 4,” letting you monitor insider sentiment before headlines move the stock. Even sudden disclosures are covered: “Enova International 8-K material events explained” highlights funding facility amendments or regulator inquiries within minutes. With real-time updates, AI summaries, and expert commentary, you can act on complete information instead of searching for it.
David Fisher, Chief Executive Officer and Director of Enova International, Inc. (ENVA), reported option exercises and subsequent share sales on September 17 and September 19, 2025. Mr. Fisher exercised option rights at an exercise price of $23.96 to acquire 35,000 shares on 09/17/2025 and 6,000 shares on 09/19/2025. On the same dates he sold 35,000 shares (weighted-average sale price $125.5488) and 6,000 shares (weighted-average sale price $125.8924), respectively. The filings disclose the sales were executed in multiple trades at specified price ranges and note that the sale(s) were effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. Following these transactions, Mr. Fisher’s reported beneficial ownership is 348,223 shares.
Enova International (ENVA) Form 144 notice shows an intended sale of 6,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $750,000 and an approximate sale date of 09/19/2025. The filer reports those shares were acquired on 02/12/2019 via stock option from Enova International. The filing also lists multiple sales by David Fisher over the past three months, totaling 88,000 shares across seven transactions, with gross proceeds reported for each sale. The notice is procedural under Rule 144 and serves to disclose proposed insider sales and recent insider transactions.
Enova International (ENVA) Form 144 notice: An officer or insider proposes to sell 35,000 shares of common stock through Merrill Lynch on the NYSE with an aggregate market value listed as $4,270,000. The shares were acquired on 02/12/2019 via a stock option from Enova International. The filing also discloses prior sales by the same person, totaling 57,000 shares sold across six transactions between 06/20/2025 and 09/04/2025, with reported gross proceeds for those sales. The filer represents they are not aware of undisclosed material adverse information and notes Rule 144 representations regarding trading plans.
Enova International, Inc. (ENVA) director Linda Johnson Rice purchased 1,700 shares of Enova common stock on 09/10/2025 at a reported price of $115.9471 per share. After this purchase she beneficially owned 6,257 shares.
The Form 4 was filed as a single reporting person filing and is signed by an attorney in fact, Sean Rahilly, dated 09/12/2025. The filing reports a straightforward open-market purchase by an insider; no derivative transactions or amendments are included.
David Fisher, Chief Executive Officer and a director of Enova International, Inc. (ENVA), reported transactions dated 09/04/2025. He acquired 20,000 shares through exercise of non-qualified stock options/SARs at an exercise price of $23.96 (reported as a non-derivative acquisition at $23.96) and concurrently sold 20,000 shares in multiple trades at a weighted-average sale price of $121.956 (actual trade prices ranged from $120.67 to $123.40). Following these transactions his beneficial ownership is reported as 348,223 shares. The option/SAR package vests in three equal installments (vesting completed by 02/12/2022) and the SAR has special exercise conditions tied to a change-in-control or qualifying offer. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/08/2025.
Enova International (ENVA) Form 144 shows a proposed sale of 20,000 common shares through Merrill Lynch (NYSE) with an aggregate market value of $2,420,000. The filer acquired the shares as stock options on 02/12/2019. The issuer's outstanding common shares are listed as 25,012,613. The filing also discloses sales by the same person totaling 37,000 shares in the past three months for gross proceeds of $4,405,547.79 across transactions dated 06/20/2025–08/29/2025. The filer attests there is no undisclosed material adverse information about the issuer.
Enova International insider transactions by CEO/Director David Fisher: The filing shows Mr. Fisher exercised employee stock options and simultaneously sold portions of his shares on August 28-29, 2025. He exercised a total of 25,000 options at an exercise price of $23.96 per share (15,000 on 08/28/2025 and 10,000 on 08/29/2025), increasing beneficial ownership represented by the exercised shares before sales to 363,223 and then 358,223 shares as sales occurred. On the same dates he sold 25,000 shares (15,000 and 10,000) at weighted-average prices of $121.8028 and $121.7989 respectively (execution ranges disclosed in the filing). Post-transactions his direct beneficial ownership is reported as 348,223 shares. The exercised options are non-qualified options with corresponding limited SARs that vest in prior years and expire February 12, 2026. The filing was signed by an attorney-in-fact on September 2, 2025.
Sean Rahilly, General Counsel and Secretary of Enova International, Inc. (ENVA), reported a sale of 2,965 shares of common stock on 08/28/2025 at a reported price of $122.635 per share. Following the transaction, Rahilly beneficially owns 100,877 shares. The Form 4 was signed on 09/02/2025 and contains no derivative transactions or additional explanatory text.
Enova International, Inc. (ENVA) Form 144 shows a proposed sale of 10,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $1,210,000.00 and an approximate sale date of 08/29/2025 on the NYSE. The securities were acquired on 02/12/2019 by stock option from Enova International. Recent reported sales by the same account (David Fisher) in the past three months total 32,000 shares with gross proceeds of $3,090,958.57 across four transactions dated 06/20/2025, 07/14/2025, 08/26/2025 and 08/28/2025. Certain filer and issuer contact fields in the filing appear blank or not provided in the extract.
FAQ
What is the current stock price of Enova Intl (ENVA)?
What is the market cap of Enova Intl (ENVA)?
